Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature

被引：0
|
作者：
Virginie Dufrost
Jessie Risse
Stéphane Zuily
Denis Wahl
机构：
[1] CHRU de Nancy,
[2] Vascular Medicine Division and Regional Competence Center For Rare Vascular And Systemic Autoimmune Diseases,undefined
[3] Inserm UMR_S 1116 at Lorraine University,undefined
来源：
Current Rheumatology Reports | 2016年 / 18卷
关键词：
Antiphospholipid syndrome; Direct oral anticoagulants; Rivaroxaban; Antiphospholipid antibodies; Thrombosis recurrence; Triple positivity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The impact of pharmaceutical care interventions on the effective and safe use of oral anticoagulants: a systematic review
    Wartenberg, Naomi Susannah
    Damen, Nikki L.
    Hersberger, Kurt E.
    Antoniou, Sotiris
    Rydant, Silas
    Arnet, Isabelle
    van den Bemt, Bart J. F.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 249 - 250
  • [22] Antiphospholipid syndrome and challenges with direct oral anticoagulants
    Booth, Stephen
    Burton, Kieran
    Hunt, Beverley
    Desborough, Michael
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2020, 81 (05)
  • [23] Direct Oral Anticoagulants (DOAC) in Antiphospholipid Syndrome?
    Specker, C.
    Doerner, T.
    Schneider, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (06): : 493 - 494
  • [24] The Role of Direct Oral Anticoagulants in Antiphospholipid Syndrome
    Alsheef, Mohammed Abdullah
    Alomar, Mukhtar
    Alarfaj, Ohoud
    AlHamidi, Hussam A.
    Zaidi, Abdul Rehman Z.
    BLOOD, 2019, 134
  • [25] Treatment of the antiphospholipid syndrome with direct oral - anticoagulants
    Bauersachs, R.
    Schellong, S.
    Stuecker, M.
    Oldenburg, J.
    Kalka, C.
    Scholz, U.
    Lindhoff-Last, E.
    PHLEBOLOGIE, 2019, 48 (04) : 271 - 274
  • [26] Comment on: "The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome"
    Yazici, Ayten
    Unlu, Ozan
    Erkan, Doruk
    THROMBOSIS RESEARCH, 2017, 157 : 82 - 83
  • [27] COST EFFECTIVENESS OF DIRECT ORAL ANTICOAGULANTS (DOACS) COMPARED WITH WARFARIN: A LITERATURE REVIEW
    Huang, Y.
    Chen, S. H.
    Wang, Y.
    Zhao, B.
    VALUE IN HEALTH, 2018, 21 : S60 - S60
  • [28] Use of New Oral Anticoagulants in Antiphospholipid Syndrome
    Arachchillage, Deepa Jayakody
    Cohen, Hannah
    CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (06)
  • [29] Use of New Oral Anticoagulants in Antiphospholipid Syndrome
    Deepa Jayakody Arachchillage
    Hannah Cohen
    Current Rheumatology Reports, 2013, 15
  • [30] Direct Oral Anticoagulants for Thromboprophylaxis in Patients with Antiphospholipid Syndrome
    Cohen, Hannah
    Efthymiou, Maria
    Gates, Carolyn
    Isenberg, David
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2018, 44 (05): : 427 - 438
12345